DataSheet5_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.docx by Qiao Liu (346535)

“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”

DataSheet2_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.docx by Qiao Liu (346535)

“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”

DataSheet3_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.docx by Qiao Liu (346535)

“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”

DataSheet1_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.docx by Qiao Liu (346535)

“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”

DataSheet6_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.docx by Qiao Liu (346535)

“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”

DataSheet4_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.docx by Qiao Liu (346535)

“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”

Data_Sheet_1_Propofol EC50 for inducing loss of consciousness in patients under combined epidural-general anesthesia or general anesthesia alone: a randomized double-blind study.do... by Jiangling Wang (11929476)

“…The epidural anesthesia on the general anesthetic (GA) requirements has not been well investigated. Therefore, we conducted the present study to explore the predicted effect-site concentration of propofol (Ce_prop) required for achieving the loss of consciousness (LOC) in 50% of patients (EC₅₀) with or without epidural anesthesia.…”

The decreasing rates of V_p with temperature. by Nazlı Tunar Özcan (14833635)

“…The V_p and the σ_t of Çankırı rock salt decrease with increasing temperatures of samples whereas the σ_c increases. …”

Supplementation. by James Phelan (354237)

“…</p><p>Results</p><p>Only 18.8% of the population had a normal vitamin D level greater than or equal to 75nmol/L. …”

Serum vitamin D levels per ethnicity category. by James Phelan (354237)

“…</p><p>Results</p><p>Only 18.8% of the population had a normal vitamin D level greater than or equal to 75nmol/L. …”

Serum vitamin D levels per gender category. by James Phelan (354237)

“…</p><p>Results</p><p>Only 18.8% of the population had a normal vitamin D level greater than or equal to 75nmol/L. …”

Ethnicity. by James Phelan (354237)

“…</p><p>Results</p><p>Only 18.8% of the population had a normal vitamin D level greater than or equal to 75nmol/L. …”

Serum vitamin D levels per categorisation). by James Phelan (354237)

“…</p><p>Results</p><p>Only 18.8% of the population had a normal vitamin D level greater than or equal to 75nmol/L. …”

Age. by James Phelan (354237)

“…</p><p>Results</p><p>Only 18.8% of the population had a normal vitamin D level greater than or equal to 75nmol/L. …”

Distribution. by James Phelan (354237)

“…</p><p>Results</p><p>Only 18.8% of the population had a normal vitamin D level greater than or equal to 75nmol/L. …”

Table_2_“If you weren't connected to the Internet, you were not alive”: experience of using social technology during COVID-19 in adults 50+.DOCX by Katrina Ling (13981107)

Table_1_“If you weren't connected to the Internet, you were not alive”: experience of using social technology during COVID-19 in adults 50+.DOCX by Katrina Ling (13981107)

Loss of Prox1a decreases PR production at 120 hours post-ablation. by Kellie Veen (17343374)

Gaussian model fitted of the number of dogs detections of SARS-CoV-2, depending on the cycle threshold (Ct) values of RT-qPCR tests for SARS-CoV-2. by Víctor M. Vidal-Martínez (18707335)

Subjects:

How the variation in inhibitor concentration throughout one day affects the value of IC₅₀/(IC₅₀ + [R]) for different Abl1 inhibitors. by J. Roadnight Sheehan (20141887)